Exploring the potential of omics technologies in medicinal plant research: a review in Colombia
Explorando el potencial de las tecnologías ómicas en la investigación de plantas medicinales: una revisión en Colombia
Bol. latinoam. Caribe plantas med. aromát; 23 (4), 2024
Publication year: 2024
This review presents advances in the implementation of high
-
throughput se
quencing and its
application to the knowledge of medicinal plants. We conducted a bibliographic search of papers
published in PubMed, Science Direct, Google Scholar, Scopus, and Web of Science databases and
analyzed the obtained data using VOSviewer (versi
on 1.6.19). Given that medicinal plants are a source of
specialized metabolites with immense therapeutic values and important pharmacological properties, plant
researchers around the world have turned their attention toward them and have begun to examine t
hem
widely. Recent advances in sequencing technologies have reduced cost and time demands and accelerated
medicinal plant research. Such research leverages full genome sequencing, as well as RNA (ribonucleic
acid) sequencing and the analysis of the transcr
iptome, to identify molecular markers of species and
functional genes that control key biological traits, as well as to understand the biosynthetic pathways of
bioactive metabolites and regulatory mechanisms of environmental responses. As such, the omics (
e.g.,
transcriptomics, metabolomics, proteomics, and genomics, among others) have been widely applied
within the study of medicinal plants, although their usage in Colombia is still few and, in some areas,
scarce.
(185)
El extracto de cloroformo (CE) y las fracciones obtenidas de las raíces de
Aldama arenaria
se
evaluaron para determinar su actividad antiproliferativa
in vitro
contra 10 líneas ce
lulares tumorales
humanas [leucemia (K
-
562), mama (MCF
-
7), ovario que expresa un fenotipo resistente a múltiples
fármacos (NCI/ADR
-
RES), melanoma (UACC
-
62), pulmón (NCI
-
H460), próstata (PC
-
3), colon (HT29),
ovario (OVCAR
-
3), glioma (U251) y riñón (786
-
0)].
CE presentó actividad antiproliferativa débil a
moderada (log GI
50
medio 1.07), mientras que las fracciones 3 y 4, enriquecidas con diterpenos de tipo
pimarane [ent
-
pimara
-
8 (14), ácido 15
-
dien
-
19
-
oico y ent
-
8(14),15
-
pimaradien
-
3
β
-
ol], presentaron
activid
ad moderada a potente para la mayoría de las líneas celulares, con un log GI
50
medio de 0.62 y
0.59, respectivamente. Los resultados mostraron una acción antiproliferativa
in vitro
prometedora de las
muestras obtenidas de
A. arenaria
, con los mejores resul
tados para NCI/ADR
-
RES, HT29 y OVCAR
-
3, y
valores de TGI que van desde 5.95 a 28.71 μg.mL
-
1, demostrando que los compuestos de esta clase
pueden ser prototipos potenciales para el descubrimiento de nuevos agentes terapéuticos